Zydus Lifesciences announces record buyback of Rs 1,100 crore at Rs 1,150 per share, representing a 13% premium to previous closing price. This marks the company's largest-ever share repurchase, following strong Q4 results showing 9% net profit growth to Rs 1,272.5 crore and 16% revenue increase to Rs 7,587 crore. The tender offer will determine eligibility through a May 29 record date, with the buyback committee retaining flexibility to adjust pricing or share quantity until one day before the record date. The announcement reflects management confidence in valuation and comes alongside a recommended final dividend of Re 1 per share. Zydus shares responded positively, closing 3% higher on the news.
Post from MarketNews_en
Log in to interact with content.